Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Dans les médias
Vous êtes Dr Adeline Ruyssen-Witrand ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Adeline Ruyssen-Witrand est rhumatologue à Toulouse (31059). Il consulte à HOPITAL PURPAN CHU TOULOUSE, BAT PIERRE PAUL RIQUET — Place DU DR BAYLAC, 31059 Toulouse.
Consulter
HOPITAL PURPAN CHU TOULOUSE
BAT PIERRE PAUL RIQUET — Place DU DR BAYLAC, 31059 Toulouse
Dr Adeline Ruyssen-Witrand, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2021Annals of the rheumatic diseases97 citations
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial
2022Joint bone spine52 citations
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
2023RMD open26 citations
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Adeline Ruyssen-Witrand consulte à HOPITAL PURPAN CHU TOULOUSE, BAT PIERRE PAUL RIQUET — Place DU DR BAYLAC, 31059 Toulouse. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 05 61 77 22 33 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Toulouse →Rhumatologues en Haute-Garonne (31) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Toulouse, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Uselessness of measuring anti-CD74 antibodies and Macrophage Migration Inhibitory Factor in axial spondyloarthritis patients in the DESIR cohort
2026The Lancet. RheumatologyPubMed
Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
2026Joint bone spinePubMed
Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry
2025International journal of molecular sciencesPubMed
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2025Diagnostics (Basel, Switzerland)PubMed
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation
2025ACR open rheumatologyPubMed
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2025Rheumatology (Oxford, England)PubMed
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2025RMD openPubMed
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study
2025Annals of the rheumatic diseasesPubMed
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
2024Clinical and experimental rheumatologyPubMed
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2024Journal of clinical medicinePubMed
Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort
2023Arthritis research & therapyPubMed
Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity
2023Rheumatology (Oxford, England)PubMed
Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years' follow-up (ESPOIR Cohort)
2023Arthritis care & researchPubMed
Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis
2023International journal of molecular sciencesPubMed
Characteristics of the (Auto)Reactive T Cells in Rheumatoid Arthritis According to the Immune Epitope Database
2022Rheumatology (Oxford, England)PubMed
Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis
2022Joint bone spinePubMed
Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry
2021BMC musculoskeletal disordersPubMed
Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients
2026The Journal of rheumatologyPubMed
Further Validation of a Questionnaire to Assess Flare in Psoriatic Arthritis: Determination of Cutoff and Longitudinal Change
2026Rheumatology (Oxford, England)PubMed
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas
2025Rheumatology (Oxford, England)PubMed
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study
2025Rheumatology (Oxford, England)PubMed
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients
2024Rheumatology (Oxford, England)PubMed
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis
2024Clinical and experimental rheumatologyPubMed
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2023Joint bone spinePubMed
Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries
2022Joint bone spinePubMed
Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]
2022Frontiers in medicinePubMed
Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study
2022Joint bone spinePubMed
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
2021Rheumatology (Oxford, England)PubMed
What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study
2026The New England journal of medicinePubMed
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
2023RMD openPubMed
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
2022RMD openPubMed
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France
2026Joint bone spinePubMed
Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry
2025ACR open rheumatologyPubMed
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2025RMD openPubMed
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study
2026Medical teacherPubMed
Standardized patient gender influences diagnostic accuracy in undergraduate medical students' cardiac OSCE interviews
2023Annals of the rheumatic diseasesPubMed
Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort'
2022Annals of the rheumatic diseasesPubMed
Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017
2025Rheumatology (Oxford, England)PubMed
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2022Joint bone spinePubMed
Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry
2026Joint bone spinePubMed
Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry
2022Frontiers in medicinePubMed
Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study
2026 · Article
Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry
2026 · Article
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
2026 · Article
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas
2025 · Article
Effect of intra-articular adipose-derived mesenchymal stromal cell versus placebo injection on pain and function in patients with knee osteoarthritis: the ADIPOA2 phase 2b randomised clinical trial
2025 · Article
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2025 · Article
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation
2025 · Article
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2025 · Article
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: insights from the the observational ReFlaP study
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.